Patents Assigned to Pepsyn Ltd.
  • Patent number: 7786081
    Abstract: Provided is use of a peptide, or a derivative of a peptide, in the manufacture of a medicament effective in stimulating fibroblasts to produce fibrillin, wherein the peptide comprises an amino acid sequence present in an ?-S2 casein precursor, said sequence comprising 3 or more amino acids, and not comprising at its N-terminal amino acid of the full ?-S2 casein precursor. Further provided is use of a peptide, or a derivative of a peptide, in the manufacture of a medicament effective in stimulating fibroblasts to produce fibrillin, wherein the peptide has an ?-S2 casein fragment activity.
    Type: Grant
    Filed: August 9, 2006
    Date of Patent: August 31, 2010
    Assignee: Pepsyn Ltd.
    Inventor: John Arthur Smith
  • Patent number: 7579315
    Abstract: Provided is use of a peptide, or a derivative of a peptide, in the manufacture of a medicament effective in alleviating or preventing periodontal disease, wherein the peptide comprises an amino acid sequence present in an ?-S2 casein precursor, said sequence comprising 3 or more amino acids, and not comprising at its N-terminus the N-terminal amino acids of the full ?-S2 casein precursor. The peptide may alternatively be any peptide having an ?-S2 casein fragment activity. Further provided is use of a peptide, or a derivative of a peptide, in the manufacture of a medicament effective in alleviating or preventing an effect of aging in skin, wherein the peptide comprises an amino acid sequence present in a n ?-S2 casein precursor, said sequence comprising 3 or more amino acids, and not comprising at its N-terminus the N-terminal amino acid of the full ?-S2 casein precursor. The peptide may alternatively be any peptide having an ?-S2 casein fragment activity.
    Type: Grant
    Filed: June 13, 2001
    Date of Patent: August 25, 2009
    Assignee: Pepsyn Ltd.
    Inventor: John Arthur Smith